Patients with greater innate immune system activity, seen in blood levels of cells like neutrophils

NEK1 gene mutations in ALS were seen in a new study to destabilize the structure

A registry data study showed that ALS patients treated with TUDCA at 1,000 mg

PrimeC, a potential combo ALS therapy, increased the survival of patient-derived motor neurons to

The gene therapy SOL-257 was well tolerated and significantly improved disease outcomes in two

Genetic and clinical factors were found to influence ALS progression and survival in PRECISION-ALS

Treatment with Relyvrio significantly reduced levels of neuroinflammatory biomarkers in the bloodstream of ALS patients

A Phase 2 HEALEY study tied pridopidine to slower progression and better respiration and speech

Taking part in recreational activities such as gardening, golfing and hunting, may increase the risk

Researcher Eva Feldman, MD, PhD has studied how occupational exposures are linked to the development

Epigenetics, or chemical changes in DNA that alter gene activity, may be key to predicting